Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- Check4 days agoChange DetectedAdded entries show Study Status and Contacts/Locations in the version history, reflecting updates to the trial's status and contact information.SummaryDifference0.4%

- Check11 days agoChange DetectedNew history entries include Study Status (2026-03-05) and Contacts/Locations (2026-03-04) along with Revision: v3.4.3. Revision: v3.4.2 was removed.SummaryDifference0.5%

- Check18 days agoChange DetectedNew history entries were added (versions 192–195). The updates include changes to the Study Status and Contacts/Locations sections.SummaryDifference0.3%

- Check25 days agoChange DetectedRecent versions add and update the Study Status and Contacts/Locations sections, showing new status details and location information.SummaryDifference0.4%

- Check33 days agoChange DetectedA 2026-02-11 version adds/updates the Study Status and Contacts/Locations sections with Revision: v3.4.2; the government funding notice and Revision: v3.4.1 were removed.SummaryDifference0.6%

- Check40 days agoChange DetectedA government funding lapse notice is displayed on the page, and the Study Status/version history includes several new entries through 2026-01-31.SummaryDifference0.6%

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.